NCT03272165 - Single Ascending Dose Study of MEDI1341 in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 17, 2017

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions

Parkinson's Disease

Interventions

DRUG

MEDI1341

Participants will receive IV infusion of MEDI1341 doses as stated in the arms' description.

DRUG

Placebo

Participants will receive IV infusion of placebo matched to MEDI1341.

Trial Locations (2)

Research Site, Madison

Research Site, Dallas